SouthState Corp’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.67M Buy
39,565
+135
+0.3% +$31.4K 0.45% 67
2025
Q4
$8.16M Sell
39,430
-1,573
-4% -$311K 0.37% 70
2025
Q3
$7.6M Sell
41,003
-3,321
-7% -$569K 0.35% 70
2025
Q2
$6.77M Sell
44,324
-1,334
-3% -$205K 0.3% 81
2025
Q1
$7.57M Sell
45,658
-10,499
-19% -$1.64M 0.35% 72
2024
Q4
$8.12M Sell
56,157
-12,965
-19% -$2.01M 0.53% 47
2024
Q3
$11.2M Sell
69,122
-7,070
-9% -$1.13M 0.77% 41
2024
Q2
$11.1M Sell
76,192
-9,667
-11% -$1.44M 0.81% 40
2024
Q1
$13.6M Sell
85,859
-21,782
-20% -$3.47M 1.06% 28
2023
Q4
$16.9M Sell
107,641
-1,306
-1% -$200K 1.44% 19
2023
Q3
$17M Buy
108,947
+1,519
+1% +$251K 1.61% 16
2023
Q2
$17.8M Sell
107,428
-3,038
-3% -$490K 1.59% 16
2023
Q1
$17.1M Sell
110,466
-1,143
-1% -$185K 1.58% 14
2022
Q4
$19.7M Buy
111,609
+2,997
+3% +$517K 1.82% 11
2022
Q3
$17.7M Buy
108,612
+1,238
+1% +$209K 1.77% 10
2022
Q2
$19.1M Buy
107,374
+2,797
+3% +$498K 1.79% 10
2022
Q1
$18.5M Buy
104,577
+1,759
+2% +$299K 1.47% 15
2021
Q4
$17.6M Sell
102,818
-202
-0.2% -$33.1K 1.37% 17
2021
Q3
$16.6M Sell
103,020
-626
-0.6% -$107K 1.4% 20
2021
Q2
$17.1M Buy
103,646
+267
+0.3% +$44.2K 1.47% 19
2021
Q1
$17M Buy
103,379
+2,097
+2% +$339K 1.59% 17
2020
Q4
$15.9M Sell
101,282
-3,314
-3% -$489K 1.57% 17
2020
Q3
$15.6M Buy
104,596
+273
+0.3% +$40.4K 1.63% 14
2020
Q2
$14.7M Buy
104,323
+10,866
+12% +$1.58M 1.8% 14
2020
Q1
$12.2M Buy
93,457
+14,070
+18% +$2M 1.82% 12
2019
Q4
$11.6M Sell
79,387
-2,194
-3% -$298K 1.33% 18
2019
Q3
$10.6M Sell
81,581
-8,968
-10% -$1.18M 1.32% 22
2019
Q2
$12.6M Sell
90,549
-26,222
-22% -$3.63M 1.45% 16
2019
Q1
$16.3M Sell
116,771
-632
-0.5% -$84.7K 1.68% 10
2018
Q4
$15.2M Sell
117,403
-6,344
-5% -$885K 1.75% 8
2018
Q3
$17.1M Sell
123,747
-24,866
-17% -$3.3M 1.76% 9
2018
Q2
$18M Sell
148,613
-8,920
-6% -$1.11M 2.03% 4
2018
Q1
$20.2M Sell
157,533
-5,517
-3% -$746K 2.32% 4
2017
Q4
$22.8M Buy
163,050
+11,933
+8% +$1.66M 2.46% 4
2017
Q3
$19.6K Buy
151,117
+8,070
+6% +$1.07M 2.2% 4
2017
Q2
$18.9M Sell
143,047
-6,054
-4% -$772K 2.44% 2
2017
Q1
$18.6M Buy
149,101
+3,946
+3% +$471K 2.42% 3
2016
Q4
$16.7M Buy
145,155
+1,738
+1% +$201K 2.4% 3
2016
Q3
$16.9M Buy
143,417
+1,666
+1% +$202K 2.58% 2
2016
Q2
$17.2M Buy
141,751
+19,056
+16% +$2.17M 2.58% 3
2016
Q1
$13.3M Sell
122,695
-12,158
-9% -$1.26M 2.06% 5
2015
Q4
$13.9M Buy
134,853
+12,400
+10% +$1.25M 2.17% 5
2015
Q3
$11.4M Sell
122,453
-15,415
-11% -$1.49M 1.75% 6
2015
Q2
$13.4M Sell
137,868
-20,432
-13% -$2.05M 1.87% 5
2015
Q1
$15.9M Sell
158,300
-24,502
-13% -$2.49M 2.26% 4
2014
Q4
$19.1M Buy
182,802
+6,019
+3% +$634K 2.99% 2
2014
Q3
$18.8M Buy
176,783
+871
+0.5% +$90.3K 2.87% 3
2014
Q2
$18.4M Sell
175,912
-3,107
-2% -$314K 3.04% 2
2014
Q1
$17.6M Sell
179,019
-3,913
-2% -$363K 2.83% 3
2013
Q4
$16.8M Sell
182,932
-3,442
-2% -$317K 2.77% 3
2013
Q3
$16.2M Buy
186,374
+9,859
+6% +$884K 3% 1
2013
Q2
$15.2M Buy
+176,515
New +$15M 3.22% 1

Other funds holding JNJ

SouthState Corp's JNJ Position: Q1 2026 in Review

SouthState Corp increased its Johnson & Johnson (JNJ) stake by 0.34% in Q1 2026, buying an estimated $31.4K and bringing the position to 39,565 shares worth $9.67M. The position accounts for 0.45% of the portfolio, ranked #67.

SouthState Corp first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $22.8M in Q4 2017. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • SouthState Corp held 39,565 shares of Johnson & Johnson worth $9.67M as of Q1 2026.
  • SouthState Corp bought 135 Johnson & Johnson shares in Q1 2026, an estimated $31.4K.
  • Johnson & Johnson made up 0.45% of SouthState Corp's portfolio in Q1 2026, its #67 holding.
  • SouthState Corp first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • SouthState Corp's Johnson & Johnson position peaked at $22.8M in Q4 2017.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on SouthState Corp's 13F filing for Q1 2026, filed 5 May 2026.